AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, MU, SCPH, ELVA, OUST, and represent 51.68% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$95M), MU (+$31M), HUMA (+$6.7M), XAIR (+$6.5M), EGRX (+$6.2M), IPWR (+$6.0M), OSPN (+$5.8M), DCTH (+$5.5M), INFN (+$5.4M), IDN (+$5.3M).
- Started 17 new stock positions in Adverum Biotechnologies, MU, PYPD, OSPN, KPRX, HUMA, EVOK, ACST, Vaccinex, BFRI. EGRX, IMMX, IDN, INFN, XBI, CYBN, XAIR.
- Reduced shares in these 10 stocks: ASPN (-$29M), INDI (-$18M), TGAN (-$17M), SPRB (-$6.2M), LPSN (-$6.1M), APLT (-$5.6M), APYX (-$5.3M), BWAY, ELUT, ABEO.
- Sold out of its positions in ABEO, Adverum Biotechnologies, APLT, APYX, ASPN, GSIT, INDI, LPSN, SPRB, TFFP. TGAN, Vaccinex, VERU.
- AIGH Capital Management was a net buyer of stock by $84M.
- AIGH Capital Management has $334M in assets under management (AUM), dropping by 31.94%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 43 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 28.5 | $95M | NEW | 1.0M | 94.89 |
|
| Micron Technology Call Option (MU) | 9.2 | $31M | NEW | 260k | 117.89 |
|
| Scpharmaceuticals (SCPH) | 5.1 | $17M | +9% | 3.4M | 5.02 |
|
| Electrovaya Com New (ELVA) | 4.5 | $15M | +22% | 4.1M | 3.65 |
|
| Ouster Com New (OUST) | 4.4 | $15M | 1.9M | 7.94 |
|
|
| Cellectar Biosciences Com New (CLRB) | 3.3 | $11M | +46% | 2.8M | 3.98 |
|
| Delcath Sys Com New (DCTH) | 3.3 | $11M | +99% | 2.4M | 4.63 |
|
| Myomo Com New (MYO) | 2.7 | $9.2M | +5% | 2.8M | 3.27 |
|
| Tela Bio (TELA) | 2.4 | $8.0M | +2% | 1.4M | 5.67 |
|
| Humacyte (HUMA) | 2.0 | $6.7M | NEW | 2.2M | 3.11 |
|
| Beyond Air (XAIR) | 1.9 | $6.5M | NEW | 3.7M | 1.74 |
|
| Coya Therapeutics Common Stock (COYA) | 1.9 | $6.4M | -37% | 649k | 9.92 |
|
| Fennec Pharmaceuticals (FENC) | 1.9 | $6.3M | +73% | 570k | 11.12 |
|
| Ideal Pwr Com New (IPWR) | 1.9 | $6.2M | +2371% | 700k | 8.90 |
|
| Eagle Pharmaceuticals (EGRX) | 1.9 | $6.2M | NEW | 1.2M | 5.24 |
|
| Theratechnologies Com New (THTX) | 1.8 | $6.1M | 3.7M | 1.63 |
|
|
| Alimera Sciences Com New (ALIM) | 1.8 | $5.9M | -31% | 1.5M | 3.90 |
|
| Onespan (OSPN) | 1.7 | $5.8M | NEW | 500k | 11.63 |
|
| Profound Med Corp Com New (PROF) | 1.7 | $5.5M | 647k | 8.53 |
|
|
| Infinera (INFN) | 1.6 | $5.4M | NEW | 889k | 6.03 |
|
| Intellicheck Com New (IDN) | 1.6 | $5.3M | NEW | 1.5M | 3.48 |
|
| Lightpath Technologies Com Cl A (LPTH) | 1.5 | $4.9M | -5% | 3.5M | 1.38 |
|
| Bk Technologies Corporation Com New (BKTI) | 1.4 | $4.8M | 331k | 14.60 |
|
|
| Immix Biopharma (IMMX) | 1.4 | $4.8M | NEW | 1.6M | 3.07 |
|
| Biodesix (BDSX) | 1.4 | $4.7M | -28% | 3.3M | 1.43 |
|
| Red Cat Hldgs (RCAT) | 1.1 | $3.8M | 5.0M | 0.77 |
|
|
| Aprea Therapeutics Com New (APRE) | 1.0 | $3.5M | +54% | 539k | 6.45 |
|
| Cognition Therapeutics (CGTX) | 1.0 | $3.5M | -6% | 1.9M | 1.82 |
|
| In8bio (INAB) | 1.0 | $3.4M | -29% | 2.9M | 1.18 |
|
| Polypid (PYPD) | 0.7 | $2.4M | NEW | 479k | 5.00 |
|
| Adverum Biotechnologies Com New | 0.7 | $2.3M | NEW | 163k | 14.14 |
|
| Cybin Ord (CYBN) | 0.6 | $1.9M | NEW | 4.7M | 0.40 |
|
| Acasti Pharma Cl A (ACST) | 0.5 | $1.7M | NEW | 497k | 3.45 |
|
| Kiora Pharmaceuticals Com New (KPRX) | 0.5 | $1.6M | NEW | 2.3M | 0.71 |
|
| Elutia Cl A Com (ELUT) | 0.4 | $1.4M | -74% | 437k | 3.15 |
|
| Brainsway Sponsored Ads (BWAY) | 0.4 | $1.3M | -76% | 243k | 5.29 |
|
| Franklin Wireless Corporation (FKWL) | 0.3 | $1.2M | 390k | 2.99 |
|
|
| Biofrontera Com New (BFRI) | 0.2 | $766k | NEW | 501k | 1.53 |
|
| Kwesst Micro Systems Com New (KWE) | 0.2 | $632k | -9% | 502k | 1.26 |
|
| Evoke Pharma Com New (EVOK) | 0.2 | $516k | NEW | 847k | 0.61 |
|
| Vaccinex | 0.1 | $433k | NEW | 58k | 7.41 |
|
| Kwesst Micro Systems *w Exp 12/09/202 (KWESW) | 0.0 | $60k | 599k | 0.10 |
|
|
| Saverone 2014 *w Exp 06/02/202 (SVREW) | 0.0 | $51k | 568k | 0.09 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2024 Q1 filed May 14, 2024
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022
- AIGH Capital Management 2022 Q1 filed May 12, 2022
- AIGH Capital Management 2021 Q4 filed Feb. 10, 2022
- AIGH Capital Management 2021 Q3 filed Nov. 12, 2021
- AIGH Capital Management 2021 Q2 filed Aug. 12, 2021
- AIGH Capital Management 2021 Q1 filed May 13, 2021
- AIGH Capital Management 2020 Q4 filed Feb. 16, 2021